관류 시스템 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Perfusion System Market size is expected to reach USD 16.93 Billion in 2034 from USD 6.23 Billion (2025) growing at a CAGR of 11.76% during 2026-2034.

The global perfusion system market is growing rapidly due to increasing demand for organ transplantation and advancements in cardiac surgeries. Perfusion systems play a critical role in maintaining blood circulation and organ viability during surgical procedures. The rising prevalence of cardiovascular diseases is a major factor driving market expansion.

Technological advancements such as automated perfusion systems and improved monitoring capabilities are key growth drivers. Hospitals and surgical centers are increasingly adopting these systems to enhance surgical precision and patient outcomes. Additionally, growing investments in healthcare infrastructure and research are supporting market development.

In the future, the market is expected to benefit from innovations in organ preservation technologies and portable perfusion devices. Increasing focus on minimally invasive procedures and improved surgical techniques will further boost demand. As organ transplantation rates rise globally, perfusion systems will remain essential in modern healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Cardiopulmonary Perfusion Systems
• Oxygenation Systems
• Others

By Age Group

• Adults
• Pediatrics

By End User

• Hospitals & ASCS
• Specialty Clinics
• Others

COMPANIES PROFILED

• LivaNova plc, XVIVO Perfusion AB, TransMedics Inc, Getinge AB, Medtronic plc, Terumo Corporation, Merck KGaA, Harvard Bioscience Inc, Lifeline Scientific Inc, ALA Scientific Instruments Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERFUSION SYSTEM MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Cardiopulmonary Perfusion Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Oxygenation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERFUSION SYSTEM MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Age Group
• 5.2. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pediatrics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERFUSION SYSTEM MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals & ASCS Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERFUSION SYSTEM MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Age Group
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Age Group
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Age Group
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Age Group
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Age Group
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PERFUSION SYSTEM INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 LivaNova Plc
  • 9.2.2 XVIVO Perfusion AB
  • 9.2.3 TransMedics Inc
  • 9.2.4 Getinge AB
  • 9.2.5 Medtronic Plc
  • 9.2.6 Terumo Corporation
  • 9.2.7 Merck KGaA
  • 9.2.8 Harvard Bioscience Inc
  • 9.2.9 Lifeline Scientific Inc
  • 9.2.10 ALA Scientific Instruments Inc